Defence Therapeutics Inc
CNSX:DTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
B
|
Burlington Stores Inc
F:BUI
|
US |
|
Atoss Software AG
F:AOF
|
DE |
|
E
|
Element Solutions Inc
F:PLQ
|
US |
|
S
|
Siemens AG
XHAM:SIE
|
DE |
|
Pointerra Ltd
OTC:PTRRF
|
AU |
|
Huuuge Inc
F:7EI
|
US |
|
G
|
Gunkul Engineering PCL
SET:GUNKUL
|
TH |
|
P
|
Pimpinan Ehsan Bhd
KLSE:PEB
|
MY |
Intrinsic Value
Is DTC undervalued or overvalued?
See the intrinsic value estimate for Defence Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Defence Therapeutics Does
Defence Therapeutics Inc. is a biotechnology company focused on developing drug delivery technology for cancer and other serious diseases. Its core work centers on engineering molecules that can carry vaccines, antibodies, or other therapeutic payloads into cells more effectively, with the goal of making those treatments work better than they would on their own. The company is still in the development stage, so its main business is research, testing, and building a pipeline of candidate therapies rather than selling a broad commercial drug portfolio.
- Headquarters
- Canada CA
- IPO date
- May 7, 2021
Earnings Waterfall
Defence Therapeutics Inc
The intrinsic value for Defence Therapeutics Inc (DTC) under the Base Case is hidden CAD.
Compared with the current market price of 0.35 CAD, the stock appears hidden.